Abstract:In this work, our primary objective was to examine the interrelationship among the serum level of chemokine (C-C motif) ligand 2 (CCL2) and plaque characteristics in coronary culprit lesions. The clinical data of 116 coronary heart disease patients who were hospitalized in the Department of Cardiology of Henan Province People's Hospital from February 2015 to June 2017 were retrospectively analyzed. The study population was subdivided according to the concentration of CCL2 into low CCL2 group and high CCL2 group. The levels of blood lipid, creatinine, and uric acid were measured, and patients underwent coronary angiography. The characteristics of the culprit lesions were detected by intravascular ultrasound, and the correlation between the serum markers and the characteristics of coronary artery plaque was analyzed. Moreover, the coronary artery disease dataset from the Gene Expression Omnibus database was downloaded and the genes regulated were analyzed by CCL2 using gene set enrichment analysis (GSEA). Patients with high CCL2 group had higher LDL-C level and L/H ratio, and lower HDL-C level than the low CCL2 group. Compared with low-level CCL2 group, coronary plaque in the high CCL2 group had higher eccentric plaque and plaque rupture, and thin cap fibroatheromas, fibrofatty and necrotic core and lower fibrous tissue. CCL2 was positively correlated with the percentage of fibrofatty and necrotic core, and negatively correlated with the percentage of fibrous tissue. Furthermore, GSEA analysis showed that samples with high CCL2 expression were enriched for genes involved in different pathways, such as cell adhesion molecules and Nod-like receptor signaling pathway. The CCL2 level was correlated with vulnerable plaques of coronary artery and had certain value in detecting vulnerable plaques. These results indicated that CCL2 could be regarded as a clinical prognostic biomarker for coronary artery disease. Impact statement Vulnerable plaques are plaques which are susceptible to rupture or thrombosis and trigger a series of adverse events such as coronary disorders. CCL2 is a soluble basic protein belonging to the CC subfamily. Previous studies have been investigated on the correlation between inflammatory factors and clinical events, but there are few studies on the correlation between CCL2 and plaque characteristics. Our study found that the high expression of CCL2 is involved in multiple processes in the genesis and progression of coronary artery disease, and would be a potential clinical prognostic indicator. In addition, high expression of CCL2 may be related to gene pathways such as Nod-like receptor signaling pathway, suggesting that CCL2 is involved in the inflammatory response and immune process of coronary artery disease.

Association Between Circulating Big Endothelin-1 and Noncalcified or Mixed Coronary Atherosclerotic Plaques

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Impact of Epicardial Adipose Tissue Volume on Hemodynamically Significant Coronary Artery Disease in Chinese Patients with Known or Suspected Coronary Artery Disease

Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy

Association Between Coronary Atherosclerotic Plaque Composition and Cardiovascular Disease Risk.

A Study of Correlation Between Circulating Endothelin and Coronary Artery Disease Degree

Correlation Between Monocyte Chemoattractant Protein-1/Chemokine (C-C Motif) Ligand 2 and Coronary Plaque Characteristics.

Elevated Levels of Plasma Endothelin-1 in Patients with Stable Angina after Coronary Angiography

Prognostic Value of Highly Sensitive C-Reactive Protein and Plaque Morphology in Coronary Artery Disease in China.

Increased Plasma Levels of Endothelin-1 and Urotensin-Ii in Patients with Coronary Heart Disease

Predictive Value of Plasma Big Endothelin-1 in Adverse Events of Patients With Coronary Artery Restenosis and Diabetes Mellitus: Beyond Traditional and Angiographic Risk Factors

Peripheral blood markers in detection of vulnerable coronary atherosclerotic plaque

Relationship between coronary hyper-intensive plaques identified by cardiovascular magnetic resonance and clinical severity of acute coronary syndrome

Prognostic value of plasma big endothelin-1 in patients with light chain cardiac amyloidosis

Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI

Study on correlation of serum level of C1q tumor necrosis factor-related protein 1 (CTRP1) with coronary atherosclerotic heart disease

Relationship of epicardial fat volume with coronary plaque characteristics, coronary artery calcification score, coronary stenosis, and CT-FFR for lesion-specific ischemia in patients with known or suspected coronary artery disease

Study on Atherosclerotic Plaque Composition in Patients with Intermediate Coronary Stenosis by Multidetector Computed Tomography Angiography,serum Matrix Metalloproteinase 9 and Soluble CD40 Ligand

Circulating Endothelial Progenitor Cells, C-Reactive Protein and Severity of Coronary Stenosis in Chinese Patients with Coronary Artery Disease

Plasma Level of Big Endothelin-1 Predicts the Prognosis in Patients with Hypertrophic Cardiomyopathy.

Diagnostic Value of Circulating Progranulin and Its Receptor EphA2 in Predicting the Atheroma Burden in Patients with Coronary Artery Disease.